EFFECTS OF A FIXED COMBINATION OF FENOFIBRATE AND PRAVASTATIN ON APOLIPOPROTEINS IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIA

被引：0

作者：

Ducobu, J. ^{[1
]}

Farnier, M. ^{[2
]}

Fruchart, J. C. ^{[3
]}

机构：

[1] CHU Tivoli, La Louviere, Belgium

[2] Point Med, Dijon, France

[3] INSERM, U545, F-59045 Lille, France

来源：

ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期

关键词：

D O I：

10.1016/S1567-5688(08)70772-4

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：193 / 193

页数：1

共 50 条

[1] SAFETY AND EFFICACY OF LONG-TERM ADMINISTRATION OF A FENOFIBRATE/PRAVASTATIN FIXED COMBINATION IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIA
Farnier, M.
Ducobu, J.
Bryniarski, L.
ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 192 - 193
[2] Pravastatin and fenofibrate in combination (Pravafenix (R)) for the treatment of high-risk patients with mixed hyperlipidemia
Farnier, Michel
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (05) : 565 - 575
[3] Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy
Farnier, Michel
Ducobu, Jean
Bryniarski, Leszek
CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2165 - 2173
[4] Effects of adding fenofibrate in high risk patients with combined hyperlipidemia not controlled by pravastatin
Farnier, M.
Ducobu, J.
Bryniarski, L.
ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 554 - 554
[5] Effects of addition of fenofibrate in high risk patients with combined hyperlipidemia not controlled by pravastatin
Ducobu, J.
Farnier, M.
Bryniarshi, L.
DIABETES & METABOLISM, 2007, 33 : S60 - S60
[6] Pravastatin and fenofibrate in combination (Pravafenix (R)) for the treatment of high-risk patients with mixed hyperlipidemia (vol 10, pg 565, 2012)
Farnier, Michel
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (02) : 253 - 254
[7] Non-lipid effects of rosuvastatin-fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia
Lee, Sang-Hak
Cho, Kyoung-Im
Kim, Jang-Young
Ahn, Young Keun
Rha, Seung-Woon
Kim, Yong-Jin
Choi, Yun-Seok
Choi, Si Wan
Jeon, Dong Woon
Min, Pil-Ki
Choi, Dong-Ju
Baek, Sang Hong
Kim, Kwon Sam
Byun, Young Sup
Jang, Yangsoo
ATHEROSCLEROSIS, 2012, 221 (01) : 169 - 175
[8] Comparison of micronized fenofibrate and pravastatin in patients with primary hyperlipidemia
Ducobu, J
VanHaelst, L
Salomon, H
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (01) : 60 - 67
[9] The fixed combination of pravastatin and fenofibrate: What can it provide?
Diaz Rodriguez, Angel
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2014, 26 : 12 - 16
[10] Efficacy and Safety of Adding Fenofibrate 160 mg in High-Risk Patients With Mixed Hyperlipidemia Not Controlled by Pravastatin 40 mg monotherapy
Farnier, Michel
Ducobu, Jean
Bryniarski, Leszek
AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (06): : 787 - 792

← 1 2 3 4 5 →